US20040228761A1 - Lateral flow test strip - Google Patents

Lateral flow test strip Download PDF

Info

Publication number
US20040228761A1
US20040228761A1 US10/868,734 US86873404A US2004228761A1 US 20040228761 A1 US20040228761 A1 US 20040228761A1 US 86873404 A US86873404 A US 86873404A US 2004228761 A1 US2004228761 A1 US 2004228761A1
Authority
US
United States
Prior art keywords
testing
sample
test strip
transfer
wicking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/868,734
Inventor
Mitchell Owens
Norman Reddick
Michael Turanchik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtox Scientific Inc
Original Assignee
Medtox Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtox Scientific Inc filed Critical Medtox Scientific Inc
Priority to US10/868,734 priority Critical patent/US20040228761A1/en
Publication of US20040228761A1 publication Critical patent/US20040228761A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements

Definitions

  • testing of bodily fluids for drugs is an increasingly important field because of increased recognition of the need for safety. For example, employers have the need to test employees in dangerous jobs such as construction, truck driving or piloting. Also, testing bodily fluid samples for other purposes, such as disease detection and other diagnostic purposes, is also important.
  • a sample usually urine, blood, or another bodily fluid
  • a sample usually urine, blood, or another bodily fluid
  • the user places a dipstick into the collection cup, assuring that all test sites on the dipstick are submerged within the fluid.
  • the dipstick remains in the sample fluid for approximately one second.
  • the dipstick is then removed by dragging it along the edge of the specimen cup to remove excess urine or other fluid.
  • Some type of absorbent paper must be placed on a flat surface, upon which the dipstick will be placed, with test sites up, to absorb all excess fluid.
  • the dipstick must not be left in the collection cup any longer than one second because the chemicals used in the test area will begin to dissolve into the sample, coming off the test area, thereby providing inaccurate test results because of cross-contamination.
  • a test strip for testing for at least one substance in a sample including a wicking member having a sample application area and an absorbent area, the sample application area and the absorbent area defining therebetween a central portion of the wicking member, the wicking member adapted to draw a sample from the sample application area through the central portion and towards the absorbent area.
  • This test strip also provides a testing member containing a testing reagent, a transfer member formed of a material through which fluid will not flow, in which the transfer member located between the central portion of the wicking member and the testing member, and a transfer path from the wicking member to the testing member, in which the transfer path is adapted to draw a portion of the sample from the central portion of the wicking member to the testing member via capillary force action, the transfer path being small enough to reduce backflow from the testing member to the wicking member.
  • the transfer member is a planar member, and/or the transfer path is a channel between two transfer members, and/or the transfer path is a channel between two sections of the transfer member, and/or the testing member is positioned adjacent to the central portion of the wicking member.
  • the transfer path is the only fluid path from the wicking member to the testing member, and/or a plurality of testing members is included, each containing reagents for separate testing of the sample.
  • the respective transfer paths may draw a portion of the sample from the central portion of the wicking member to each testing member.
  • the testing member receives the sample only from the central portion of the wicking member.
  • An alternate embodiment provides a test strip for testing for a plurality of substances in a sample that includes: a wicking member having a sample application area and an absorbent area, the sample application area and the absorbent area defining therebetween a central portion of the wicking member, the wicking member adapted to draw a sample from the sample application area through the central portion and towards the absorbent area; a plurality of adulterant testing members each containing a testing reagent for separate testing of the sample for adulterants; and a plurality of transfer paths, each transfer path extending from the central portion of the wicking member to a respective testing member, each transfer path adapted to draw a portion of the sample from the central portion of the wicking member to the respective testing member via capillary force action, the transfer paths being small enough to reduce backflow from the testing members to the wicking member.
  • the testing members receive the sample only from the central portion of the wicking member.
  • an embodiment may further include a transfer member formed of a material through which fluid will not flow, the transfer member located between the central portion of the wicking member and the testing members.
  • the transfer paths are formed from passages within a transfer member, the transfer member formed of a material through which fluid will not flow, and the transfer member is located between the central portion of the wicking member and the testing members, and/or the testing members are separated and isolated from each other, and/or the transfer paths are separate and isolated from each other.
  • a test strip that separates the testing member holding the testing reagent from the sample holding member itself.
  • This provides a simpler testing process that helps prevent unsanitary conditions and cross-contamination.
  • the test strip can be placed into a carrier device or instrument to assist in handling and containing the sample being tested, such as urine, blood, body fluids or any other type of sample extraction.
  • the test strip and associated methods make the testing process easier, more sanitary, and less confusing when processing multiple samples.
  • FIG. 1 shows a side view of one embodiment of a test strip.
  • FIG. 2 shows a top view of the test strip of FIG. 1.
  • FIG. 3 is a side view of the test strip of FIG. 1.
  • FIG. 4 is a front view of the test strip of FIG. 1.
  • FIG. 5 is an isometric view of the test strip of FIG. 1.
  • FIG. 6 is an exploded view of the test strip of FIG. 1.
  • FIG. 7 is a top view of another embodiment of a test strip.
  • FIG. 8 is a top view of another embodiment of a test strip.
  • FIG. 9 is a top view of another embodiment of a test strip.
  • FIG. 10 is a front isometric view of one embodiment of a housing.
  • FIG. 11 is a back isometric view of the housing of FIG. 10.
  • FIG. 12 is a back view of the housing of FIG. 10.
  • FIG. 13 is a front view of the housing of FIG. 10.
  • FIG. 14 is a sectional view of the housing of FIG. 10.
  • FIG. 15 is another sectional view of the housing of FIG. 10.
  • FIGS. 1-6 show one embodiment of a lateral flow test strip 100 .
  • Test strip 100 includes a first layer, such as a wicking member 101 , for holding and carrying the sample.
  • Wicking member 101 includes a sample application area 115 and an absorbent area 113 .
  • wicking member 101 is fabricated from an efficient liquid transferring material, such as a wicking membrane material, that allows a sample placed on the sample application area 115 to freely flow to the absorbent area 113 .
  • Test strip 100 also includes a capillary transfer plane member 102 and a plurality of assorted test pads or testing members 108 - 112 .
  • test strip 100 can include a backing layer 114 to provide support for wicking member 101 .
  • the backing member 114 may be Mylar or other rigid support material.
  • Capillary transfer plane member 102 is adhesively attached to one side of the first layer of wicking member 101 . It is located so that it is sandwiched between the first layer and the testing members 108 - 112 .
  • the wicking member is longer than the capillary transfer plane member so that sample application area 115 of wicking member 101 is exposed so that a sample can be placed thereon.
  • capillary transfer plane member 102 is fabricated from Mylar or other suitable material.
  • Member 102 includes a plurality of capillary transfer passages 103 - 107 . These passages provide a capillary force action to draw a portion of a sample placed on wicking member 101 to be drawn upwards through the passage and into contact with the testing members 108 - 112 .
  • Each of the capillary transfer passages are of a suitable size for providing correct flow rate of the sample. In one embodiment, the passages are holes of approximately 0.5 to 2.5 millimeters in diameter. In another embodiment, each passage is a hole approximately 2 millimeters in diameter. Those skilled in the art will appreciate that the exact size of the hole is determined by the viscosity of the liquid and the desired flow rate.
  • the passages can be channels, such as channels 801 - 805 shown in FIG. 8.
  • any other transfer means may be used instead of holes or channels, such as star-shaped holes or other shapes.
  • more than one hole, channel, or other shaped passage may be located under each test area, as shown in FIG. 9, which shows a test strip 100 which includes a pair of holes 901 and 902 beneath each testing member 108 - 112 .
  • the exact size, shape, and number of the capillary transfer passages depends on the viscosity of the fluid sample and the desired flow rate.
  • the pressure at the inlet of a given capillary transfer passage 108 - 112 is sufficient to prevent an immediate back-flushing effect into the wicking member 101 . This prevents any cross-contamination of or between the separate testing members 108 - 112 .
  • capillary transfer plane member 102 also includes an indexing hole 610 (see FIGS. 6 and 7). Indexing hole 610 provides a means during manufacturing for aligning passages 103 - 107 so that they are the proper distance apart.
  • the size of the layers may vary considerably, as will be appreciated by those skilled in the art.
  • the first layer such as wicking member 101
  • member 102 is approximately 56 millimeters long by 5 millimeters wide and 0.50 millimeters thick.
  • Testing members 108 - 112 are testing areas or test pads which are fabricated from porous materials that will hold specific testing reagents.
  • the testing reagents in the testing members 108 - 112 can provide for separate testing of a single sample.
  • the testing members can include a color coded, positive or negative, test result.
  • the testing members are located over the capillary transfer passages 103 - 107 in the capillary transfer plane member 102 .
  • member 102 includes adhesive zones 601 - 605 for attaching testing members 108 - 112 over its capillary transfer passages 103 - 107 (see FIG. 6). It is noted that the number of testing members shown in the Figures is exemplary, and that embodiments could include more or less, depending on the need.
  • the capillary transfer passages 103 - 107 are shaped and designed a suitable size for providing correct flow rate of the sample.
  • the sample will continue on to each adjacent capillary transfer passage 104 - 107 in the same manner until it reaches the absorbent area 113 .
  • This system provides that a user need only add a few drops to the application area 115 . This lessens the complexity of doing multiple tests since there is no need to carefully time the immersion of the test strip in the fluid sample. Also, since immersion is not required, the present system provides for a neater, more sanitary testing system.
  • FIGS. 10-15 show one embodiment of a sample testing device comprising a carrier device or housing 1200 having a plurality of openings and a test strip 100 located within the housing (the test strip is shown in outline in FIG. 12.
  • the test strip 100 is substantially as described above, and will not be described further).
  • Housing 1200 includes a first, front member 1201 and a second member (not shown) which provides a backing for the housing. The front and back members can be attached by attaching members 1301 .
  • Housing 1200 also includes a plurality of openings, such as viewing openings 1205 - 1209 and sample application openings 1202 and 1203 .
  • the test strip is contained within carrier device 1200 so that each of the testing members 108 - 112 is viewable through at least one of the plurality of openings 1205 - 1209 of the housing 1200 .
  • the sample is deposited on the sample application area 115 of the test strip 100 through opening 1202 of the housing.
  • carrier device or housing 1200 can also include another sample opening 1203 and another viewing opening 1204 . This provides that another type of testing system can be incorporated into the carrier device.
  • embodiments of the test strip and its associated methods represent an advance over dipstick format tests in which the sample is introduced to the testing area by submerging the dipstick into the sample being tested or have the sample introduced directly onto the test areas.
  • the lateral flow test strip 100 placed within the carrier device 1200 provides that a sample can be tightly controlled, isolated and identified, even after introducing the sample into the sample application area 115 .
  • the lateral flow test strip in a carrier device provides an area for permanent and efficient sample/patient identification.
  • the present system can be used for the conversion of adulterant or urinalysis dipsticks that screen for adulterants in urine samples or uranalysis tests that screen for Ph factors, for example.
  • the system includes a test strip 100 for testing a sample.
  • Test strip 100 having a first layer, such as a wicking member 101 , for holding and carrying the sample.
  • the test strip includes a second layer next to the first layer comprising a capillary transfer plane member 102 having a plurality of capillary transfer passages 103 - 107 for drawing a portion of the sample away from the wicking member 101 .
  • the test strip also includes and a plurality of testing members 108 - 112 , each testing member located over at least one of the plurality of capillary transfer passages, each testing member 108 - 112 for receiving the portion of the sample from the capillary passage(s) beneath the testing member.
  • the wicking member 101 comprises a first end having a sample application area 115 and a second end comprising an absorbent area 113 .
  • the capillary transfer passages comprises a hole of approximately 0.5 to 2.5 millimeters in diameter.
  • the capillary passage can be shaped as a channel, star, or other shape to provide the correct flow depending on the flow rate desired by the designer.
  • Each of the plurality of testing members 108 - 112 comprise a porous material holding a testing reagent.
  • the present system provides a lateral flow test strip 100 that can be placed into a carrier device 1200 or instrument to assist in handling and containing the sample being tested, such as urine, blood, body fluids or any other type of sample extraction.
  • the lateral flow test strip 100 provides a method for converting any type of dipstick style test, such as adulterants, glucose, urinalysis, etc. to an easy and sanitary format by enclosing and controlling the sample.
  • the various embodiments of the test strip and associated methods generally make the testing process easier, more sanitary, and less confusing when processing multiple samples.

Abstract

The present invention provides a test strip having a first layer comprising a wicking member and a second layer comprising a capillary transfer plane member. The capillary transfer plane has a plurality of capillary transfer passages. The capillary transfer passages can comprise a hole, channel, or other shape to control sample flow rate. Located above the one or more capillary transfer passages are a plurality of testing members. The test strip can include a third layer next to the wicking member, the third layer comprising a backing member for providing support to the wicking member. Another aspect of the present invention provides a sample testing device, which includes a housing having a plurality of openings, and a test strip as described above, wherein a sample application area of the test strip is accessible through one of the openings in the housing, and each of the testing members is viewable through one of the openings of the housing.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • This is a divisional application of U.S. application Ser. No. 10/347,951, filed Jan. 21, 2003, which in turn is a continuation of U.S. application Ser. No. 09/889,270, now U.S. Pat. No. 6,566,051, which claims the benefit under 35 U.S.C. 120 to PCT application No. WO 00/42430, filed on Jan. 14, 2000, published in English as per PCT article 21(2), which in turn claims priority to provisional U.S. application Ser. No. 60/115,984, filed on Jan. 15, 1999.[0001]
  • BACKGROUND
  • Testing of bodily fluids for drugs is an increasingly important field because of increased recognition of the need for safety. For example, employers have the need to test employees in dangerous jobs such as construction, truck driving or piloting. Also, testing bodily fluid samples for other purposes, such as disease detection and other diagnostic purposes, is also important. [0002]
  • In the past, assorted systems for collecting and testing samples have been used. For example in one method, when a test is needed, a sample, usually urine, blood, or another bodily fluid, is deposited into a cup. Currently, the user places a dipstick into the collection cup, assuring that all test sites on the dipstick are submerged within the fluid. The dipstick remains in the sample fluid for approximately one second. The dipstick is then removed by dragging it along the edge of the specimen cup to remove excess urine or other fluid. Some type of absorbent paper must be placed on a flat surface, upon which the dipstick will be placed, with test sites up, to absorb all excess fluid. The dipstick must not be left in the collection cup any longer than one second because the chemicals used in the test area will begin to dissolve into the sample, coming off the test area, thereby providing inaccurate test results because of cross-contamination. [0003]
  • Overall, this is an unsanitary process that can result in urine getting onto counter-tops, clothes, instruments, etc. Also, if multiple samples are being tested, as is the case in a laboratory environment, it is difficult to efficiently identify multiple samples once they are removed from the collection cup. [0004]
  • For the reasons stated above, and for other reasons stated below which will become apparent to those skilled in the art upon reading and understanding the present specification, there is a need in the art for a better method and apparatus for performing testing of samples. [0005]
  • SUMMARY
  • Embodiments of the present invention answer the need described. For example, in one embodiment, a test strip for testing for at least one substance in a sample, including a wicking member having a sample application area and an absorbent area, is disclosed, the sample application area and the absorbent area defining therebetween a central portion of the wicking member, the wicking member adapted to draw a sample from the sample application area through the central portion and towards the absorbent area. This test strip also provides a testing member containing a testing reagent, a transfer member formed of a material through which fluid will not flow, in which the transfer member located between the central portion of the wicking member and the testing member, and a transfer path from the wicking member to the testing member, in which the transfer path is adapted to draw a portion of the sample from the central portion of the wicking member to the testing member via capillary force action, the transfer path being small enough to reduce backflow from the testing member to the wicking member. [0006]
  • In further embodiments of the test strip described above, the transfer member is a planar member, and/or the transfer path is a channel between two transfer members, and/or the transfer path is a channel between two sections of the transfer member, and/or the testing member is positioned adjacent to the central portion of the wicking member. In additional embodiments, the transfer path is the only fluid path from the wicking member to the testing member, and/or a plurality of testing members is included, each containing reagents for separate testing of the sample. For this embodiment, the respective transfer paths may draw a portion of the sample from the central portion of the wicking member to each testing member. In an additional embodiment, the testing member receives the sample only from the central portion of the wicking member. [0007]
  • An alternate embodiment provides a test strip for testing for a plurality of substances in a sample that includes: a wicking member having a sample application area and an absorbent area, the sample application area and the absorbent area defining therebetween a central portion of the wicking member, the wicking member adapted to draw a sample from the sample application area through the central portion and towards the absorbent area; a plurality of adulterant testing members each containing a testing reagent for separate testing of the sample for adulterants; and a plurality of transfer paths, each transfer path extending from the central portion of the wicking member to a respective testing member, each transfer path adapted to draw a portion of the sample from the central portion of the wicking member to the respective testing member via capillary force action, the transfer paths being small enough to reduce backflow from the testing members to the wicking member. [0008]
  • In further embodiments of the test strip described above, the testing members receive the sample only from the central portion of the wicking member. Alternately, or in addition, an embodiment may further include a transfer member formed of a material through which fluid will not flow, the transfer member located between the central portion of the wicking member and the testing members. In further embodiments, the transfer paths are formed from passages within a transfer member, the transfer member formed of a material through which fluid will not flow, and the transfer member is located between the central portion of the wicking member and the testing members, and/or the testing members are separated and isolated from each other, and/or the transfer paths are separate and isolated from each other. [0009]
  • Advantageously, a test strip is provided that separates the testing member holding the testing reagent from the sample holding member itself. This provides a simpler testing process that helps prevent unsanitary conditions and cross-contamination. The test strip can be placed into a carrier device or instrument to assist in handling and containing the sample being tested, such as urine, blood, body fluids or any other type of sample extraction. The test strip and associated methods make the testing process easier, more sanitary, and less confusing when processing multiple samples.[0010]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a side view of one embodiment of a test strip. [0011]
  • FIG. 2 shows a top view of the test strip of FIG. 1. [0012]
  • FIG. 3 is a side view of the test strip of FIG. 1. [0013]
  • FIG. 4 is a front view of the test strip of FIG. 1. [0014]
  • FIG. 5 is an isometric view of the test strip of FIG. 1. [0015]
  • FIG. 6 is an exploded view of the test strip of FIG. 1. [0016]
  • FIG. 7 is a top view of another embodiment of a test strip. [0017]
  • FIG. 8 is a top view of another embodiment of a test strip. [0018]
  • FIG. 9 is a top view of another embodiment of a test strip. [0019]
  • FIG. 10 is a front isometric view of one embodiment of a housing. [0020]
  • FIG. 11 is a back isometric view of the housing of FIG. 10. [0021]
  • FIG. 12 is a back view of the housing of FIG. 10. [0022]
  • FIG. 13 is a front view of the housing of FIG. 10. [0023]
  • FIG. 14 is a sectional view of the housing of FIG. 10. [0024]
  • FIG. 15 is another sectional view of the housing of FIG. 10.[0025]
  • DETAILED DESCRIPTION
  • In the following detailed description, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration specific embodiments in which the invention may be practiced. It is understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present invention. [0026]
  • FIGS. 1-6 show one embodiment of a lateral [0027] flow test strip 100. Test strip 100 includes a first layer, such as a wicking member 101, for holding and carrying the sample. Wicking member 101 includes a sample application area 115 and an absorbent area 113. In one embodiment, wicking member 101 is fabricated from an efficient liquid transferring material, such as a wicking membrane material, that allows a sample placed on the sample application area 115 to freely flow to the absorbent area 113. Test strip 100 also includes a capillary transfer plane member 102 and a plurality of assorted test pads or testing members 108-112. In one embodiment, test strip 100 can include a backing layer 114 to provide support for wicking member 101. The backing member 114 may be Mylar or other rigid support material.
  • Capillary [0028] transfer plane member 102 is adhesively attached to one side of the first layer of wicking member 101. It is located so that it is sandwiched between the first layer and the testing members 108-112. In one embodiment, the wicking member is longer than the capillary transfer plane member so that sample application area 115 of wicking member 101 is exposed so that a sample can be placed thereon. In one embodiment, capillary transfer plane member 102 is fabricated from Mylar or other suitable material.
  • [0029] Member 102 includes a plurality of capillary transfer passages 103-107. These passages provide a capillary force action to draw a portion of a sample placed on wicking member 101 to be drawn upwards through the passage and into contact with the testing members 108-112. Each of the capillary transfer passages are of a suitable size for providing correct flow rate of the sample. In one embodiment, the passages are holes of approximately 0.5 to 2.5 millimeters in diameter. In another embodiment, each passage is a hole approximately 2 millimeters in diameter. Those skilled in the art will appreciate that the exact size of the hole is determined by the viscosity of the liquid and the desired flow rate. Moreover, it is noted that if the passage is too small, surface tension of the sample fluid will prevent flow and if the passage is too large, the capillary action will not be activated. Alternatively, the passages can be channels, such as channels 801-805 shown in FIG. 8. Alternatively, any other transfer means may be used instead of holes or channels, such as star-shaped holes or other shapes.
  • Furthermore, more than one hole, channel, or other shaped passage may be located under each test area, as shown in FIG. 9, which shows a [0030] test strip 100 which includes a pair of holes 901 and 902 beneath each testing member 108-112. As noted above, the exact size, shape, and number of the capillary transfer passages depends on the viscosity of the fluid sample and the desired flow rate. Advantageously, the pressure at the inlet of a given capillary transfer passage 108-112 is sufficient to prevent an immediate back-flushing effect into the wicking member 101. This prevents any cross-contamination of or between the separate testing members 108-112. Such cross-contamination can be caused by the cross-mixing of the reagents on the pads or a combination of reagent and sample being reintroduced back to the main sample in the wicking member. Also, the passages provide that test strip 100 does not have any testing reagents located on the wicking member 101 or on any material in direct contact with the wicking member. The testing reagents on the testing members 108-112 are isolated from the first layer containing the sample and they receive the necessary sample volume intermittently as the sample runs along the first layer material. Advantageously, this also prevents cross contamination which would result from a contrary system. In one embodiment, capillary transfer plane member 102 also includes an indexing hole 610 (see FIGS. 6 and 7). Indexing hole 610 provides a means during manufacturing for aligning passages 103-107 so that they are the proper distance apart.
  • The size of the layers may vary considerably, as will be appreciated by those skilled in the art. However, by way of example, but not limitation, in one embodiment, the first layer, such as [0031] wicking member 101, is approximately 70 millimeters long by 5 millimeters wide and 0.20 millimeters thick. Also, way of example, but not limitation, in one embodiment, member 102 is approximately 56 millimeters long by 5 millimeters wide and 0.50 millimeters thick.
  • Testing members [0032] 108-112 are testing areas or test pads which are fabricated from porous materials that will hold specific testing reagents. The testing reagents in the testing members 108-112 can provide for separate testing of a single sample. In one embodiment, the testing members can include a color coded, positive or negative, test result. The testing members are located over the capillary transfer passages 103-107 in the capillary transfer plane member 102. In one embodiment, member 102 includes adhesive zones 601-605 for attaching testing members 108-112 over its capillary transfer passages 103-107 (see FIG. 6). It is noted that the number of testing members shown in the Figures is exemplary, and that embodiments could include more or less, depending on the need.
  • As a sample flows along the wicking [0033] member 101, some of the sample will be pulled through the first capillary transfer passage 103 and saturate the first testing member 108. As noted above, the capillary transfer passages 103-107 are shaped and designed a suitable size for providing correct flow rate of the sample. The sample will continue on to each adjacent capillary transfer passage 104-107 in the same manner until it reaches the absorbent area 113. This system provides that a user need only add a few drops to the application area 115. This lessens the complexity of doing multiple tests since there is no need to carefully time the immersion of the test strip in the fluid sample. Also, since immersion is not required, the present system provides for a neater, more sanitary testing system.
  • FIGS. 10-15 show one embodiment of a sample testing device comprising a carrier device or [0034] housing 1200 having a plurality of openings and a test strip 100 located within the housing (the test strip is shown in outline in FIG. 12. The test strip 100 is substantially as described above, and will not be described further). Housing 1200 includes a first, front member 1201 and a second member (not shown) which provides a backing for the housing. The front and back members can be attached by attaching members 1301. Housing 1200 also includes a plurality of openings, such as viewing openings 1205-1209 and sample application openings 1202 and 1203. The test strip is contained within carrier device 1200 so that each of the testing members 108-112 is viewable through at least one of the plurality of openings 1205-1209 of the housing 1200. In one example of using the present system for performing a test of a sample, the sample is deposited on the sample application area 115 of the test strip 100 through opening 1202 of the housing. In one embodiment, carrier device or housing 1200 can also include another sample opening 1203 and another viewing opening 1204. This provides that another type of testing system can be incorporated into the carrier device.
  • As will be recognized by one skilled in the art, embodiments of the test strip and its associated methods represent an advance over dipstick format tests in which the sample is introduced to the testing area by submerging the dipstick into the sample being tested or have the sample introduced directly onto the test areas. Advantageously, the lateral [0035] flow test strip 100 placed within the carrier device 1200 provides that a sample can be tightly controlled, isolated and identified, even after introducing the sample into the sample application area 115. For example, if multiple samples are being tested, as is the case in a laboratory environment, it is difficult to efficiently identify multiple samples from different patients once the samples are removed from a collection cup. Advantageously, in the present system, the lateral flow test strip in a carrier device provides an area for permanent and efficient sample/patient identification. Moreover, the present system can be used for the conversion of adulterant or urinalysis dipsticks that screen for adulterants in urine samples or uranalysis tests that screen for Ph factors, for example.
  • A sample testing system has been described. In one embodiment, the system includes a [0036] test strip 100 for testing a sample. Test strip 100 having a first layer, such as a wicking member 101, for holding and carrying the sample. The test strip includes a second layer next to the first layer comprising a capillary transfer plane member 102 having a plurality of capillary transfer passages 103-107 for drawing a portion of the sample away from the wicking member 101. The test strip also includes and a plurality of testing members 108-112, each testing member located over at least one of the plurality of capillary transfer passages, each testing member 108-112 for receiving the portion of the sample from the capillary passage(s) beneath the testing member. In one embodiment, the wicking member 101 comprises a first end having a sample application area 115 and a second end comprising an absorbent area 113. In one embodiment, the capillary transfer passages comprises a hole of approximately 0.5 to 2.5 millimeters in diameter. Alternatively, the capillary passage can be shaped as a channel, star, or other shape to provide the correct flow depending on the flow rate desired by the designer. Each of the plurality of testing members 108-112 comprise a porous material holding a testing reagent.
  • In another aspect, the present system provides a lateral [0037] flow test strip 100 that can be placed into a carrier device 1200 or instrument to assist in handling and containing the sample being tested, such as urine, blood, body fluids or any other type of sample extraction. The lateral flow test strip 100 provides a method for converting any type of dipstick style test, such as adulterants, glucose, urinalysis, etc. to an easy and sanitary format by enclosing and controlling the sample. The various embodiments of the test strip and associated methods generally make the testing process easier, more sanitary, and less confusing when processing multiple samples.
  • It is understood that the above description is intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. [0038]

Claims (16)

1-25 (cancelled)
26. A test strip for testing for at least one substance in a sample, comprising:
a wicking member having a sample application area and an absorbent area, the sample application area and the absorbent area defining therebetween a central portion of the wicking member, the wicking member adapted to draw a sample from the sample application area through the central portion and towards the absorbent area;
a testing member containing a testing reagent;
a transfer member formed of a material through which fluid will not flow, the transfer member located between the central portion of the wicking member and the testing member; and
a transfer path from the wicking member to the testing member, the transfer path adapted to draw a portion of the sample from the central portion of the wicking member to the testing member via capillary force action, the transfer path being small enough to reduce backflow from the testing member to the wicking member.
27. The test strip of claim 26, wherein the transfer member is a planar member.
28. The test strip of claim 26, wherein the transfer path is a channel between two transfer members.
29. The test strip of claim 26, wherein the transfer path is a channel between two sections of the transfer member.
30. The test strip of claim 26, wherein the testing member is positioned adjacent to the central portion of the wicking member.
31. The test strip of claim 26, wherein the transfer path is the only fluid path from the wicking member to the testing member.
32. The test strip of claim 26, further including a plurality of testing members each containing reagents for separate testing of the sample.
33. The test strip of claim 32, wherein respective transfer paths draw a portion of the sample from the central portion of the wicking member to each testing member.
34. The test strip of claim 26, wherein the testing member receives the sample only from the central portion of the wicking member.
35. A test strip for testing for a plurality of substances in a sample, comprising:
a wicking member having a sample application area and an absorbent area, the sample application area and the absorbent area defining therebetween a central portion of the wicking member, the wicking member adapted to draw a sample from the sample application area through the central portion and towards the absorbent area;
a plurality of adulterant testing members each containing a testing reagent for separate testing of the sample for adulterants; and
a plurality of transfer paths, each transfer path extending from the central portion of the wicking member to a respective testing member, each transfer path adapted to draw a portion of the sample from the central portion of the wicking member to the respective testing member via capillary force action, the transfer paths being small enough to reduce backflow from the testing members to the wicking member.
36. The test strip of claim 35, wherein the testing members receive the sample only from the central portion of the wicking member.
37. The test strip of claim 35, further including a transfer member formed of a material through which fluid will not flow, the transfer member located between the central portion of the wicking member and the testing members.
38. The test strip of claim 35, wherein the transfer paths are formed from passages within a transfer member, the transfer member formed of a material through which fluid will not flow, the transfer member located between the central portion of the wicking member and the testing members.
39. The test strip of claim 35, wherein the testing members are separated and isolated from each other.
40. The test strip of claim 35, wherein the transfer paths are separate and isolated from each other.
US10/868,734 1999-01-15 2004-06-15 Lateral flow test strip Abandoned US20040228761A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/868,734 US20040228761A1 (en) 1999-01-15 2004-06-15 Lateral flow test strip

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11598499P 1999-01-15 1999-01-15
US09/889,270 US6566051B1 (en) 1999-01-15 2000-01-14 Lateral flow test strip
US10/347,951 US20040023364A1 (en) 1999-01-15 2003-01-21 Lateral flow test strip
US10/868,734 US20040228761A1 (en) 1999-01-15 2004-06-15 Lateral flow test strip

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/347,951 Division US20040023364A1 (en) 1999-01-15 2003-01-21 Lateral flow test strip

Publications (1)

Publication Number Publication Date
US20040228761A1 true US20040228761A1 (en) 2004-11-18

Family

ID=22364559

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/889,270 Expired - Lifetime US6566051B1 (en) 1999-01-15 2000-01-14 Lateral flow test strip
US10/347,951 Abandoned US20040023364A1 (en) 1999-01-15 2003-01-21 Lateral flow test strip
US10/868,734 Abandoned US20040228761A1 (en) 1999-01-15 2004-06-15 Lateral flow test strip
US11/134,641 Abandoned US20050208677A1 (en) 1999-01-15 2005-05-20 Lateral flow test strip

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/889,270 Expired - Lifetime US6566051B1 (en) 1999-01-15 2000-01-14 Lateral flow test strip
US10/347,951 Abandoned US20040023364A1 (en) 1999-01-15 2003-01-21 Lateral flow test strip

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/134,641 Abandoned US20050208677A1 (en) 1999-01-15 2005-05-20 Lateral flow test strip

Country Status (4)

Country Link
US (4) US6566051B1 (en)
EP (1) EP1159611A1 (en)
CA (1) CA2360044A1 (en)
WO (1) WO2000042430A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012009760A1 (en) 2010-07-20 2012-01-26 Cephalon Australia Pty Ltd Anti-il-23 heterodimer specific antibodies
WO2012142656A1 (en) 2011-04-18 2012-10-26 Garvan Institute Of Medical Research Method of diagnosing cancer
CN103808714A (en) * 2012-11-05 2014-05-21 郑兆珉 Biomedical detection device
WO2016041010A1 (en) 2014-09-15 2016-03-24 Garvan Institute Of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
WO2016177805A1 (en) 2015-05-05 2016-11-10 Mesoblast International Sàrl Potency assay
US9840559B2 (en) 2013-02-01 2017-12-12 The Regents Of The University Of California Anti-CD83 antibodies and use thereof
WO2018202853A1 (en) 2017-05-04 2018-11-08 Mesoblast International Sàrl Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
EP3495389A1 (en) 2011-09-30 2019-06-12 Teva Pharmaceuticals Australia Pty Ltd Antibodies against tl1a and uses thereof
WO2020141473A1 (en) 2019-01-02 2020-07-09 Mesoblast International Sárl Method for treating lower back pain
US10870704B2 (en) 2014-10-23 2020-12-22 Kira Biotech Pty Limited CD83 binding proteins and uses thereof
WO2022034467A1 (en) 2020-08-10 2022-02-17 Mesoblast International Sarl A composition comprising mesenchymal precursor or stem cells and their use
EP4219552A2 (en) 2013-02-07 2023-08-02 CSL Ltd. Il-11r binding proteins and uses thereof
WO2024009226A1 (en) 2022-07-05 2024-01-11 Mesoblast International Sarl Cryopreserved intermediate and potency assay for same

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042430A1 (en) * 1999-01-15 2000-07-20 Medtox Scientific, Inc. Lateral flow test strip
US6818452B2 (en) * 2001-04-23 2004-11-16 Branan Medical Corp. Lateral flow contact test apparatus
JP4283512B2 (en) * 2002-09-09 2009-06-24 アークレイ株式会社 Test tool and method of manufacturing the same
GB0300820D0 (en) * 2003-01-14 2003-02-12 Diagnoswiss Sa Membrane-microchannel strip
US7595196B2 (en) * 2003-09-23 2009-09-29 Oakville Hong Kong Company Limited Lateral flow assay devices with inhibiting backflow of the sample and methods of use
BRPI0415886A (en) 2003-10-29 2007-01-09 Mec Dynamics Corp disposable strips and method of determining hemoglobin percentage of hbalc
US7241417B2 (en) * 2004-07-29 2007-07-10 Savyon Diagnostics Ltd. Assay device
ES2562406T3 (en) 2005-01-31 2016-03-04 Realbio Technologies Ltd. Multi-stage reaction lateral flow capillary device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US20060246599A1 (en) * 2005-04-29 2006-11-02 Sarah Rosenstein Lateral flow device
WO2008122241A1 (en) * 2007-04-04 2008-10-16 Diagcor Bioscience Incorporation Limited Rapid protein analyses and the device thereof
US9952211B2 (en) 2008-06-29 2018-04-24 Realbio Technologies Ltd. Liquid-transfer device particularly useful as a capturing device in a biological assay process
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
DE102010002921A1 (en) 2010-03-16 2011-09-22 Senslab-Gesellschaft Zur Entwicklung Und Herstellung Bioelektrochemischer Sensoren Mbh Microfluidic multiple measuring chamber arrangement
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
US20130164193A1 (en) 2011-12-22 2013-06-27 Life Technologies Corporation Sequential lateral flow capillary device for analyte determination
PE20151873A1 (en) 2013-03-14 2016-01-06 Kasing Cheng TEST STRIP HOUSING SYSTEM
GB2522177B (en) * 2013-11-07 2018-07-11 Brytech Design & Engineering Project Man Limited Improvements in and relating to sampling
CN106461642A (en) * 2014-03-19 2017-02-22 警戒生物科学公司 Device for detection of disease states and applications of same
EP3126486B1 (en) 2014-04-02 2019-07-03 Chembio Diagnostic Systems, Inc. Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
WO2017044111A1 (en) * 2015-09-11 2017-03-16 Vigilant Biosciences, Inc. Device for early detection of disease states
USD865992S1 (en) * 2015-11-02 2019-11-05 Jon A. Petty Fluid test strip
WO2017205416A1 (en) * 2016-05-23 2017-11-30 Vanderbilt University Devices, kits, and methods for monitoring disease states
WO2019059930A1 (en) * 2017-09-22 2019-03-28 Emmanuel Mpock System for measuring total hemoglobin in blood and method of doing the same
FR3100889B1 (en) * 2019-09-17 2021-09-10 Innopsys Biological fluid sample collection device

Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215197A (en) * 1978-08-04 1980-07-29 Miles Laboratories, Inc. Test means and method for creatinine determination
US4256693A (en) * 1978-06-06 1981-03-17 Fuji Photo Film Co., Ltd. Multilayered integral chemical analysis element for the blood
US4529708A (en) * 1983-04-07 1985-07-16 American Monitor Corporation Assay for the determination of creatinine
US4543325A (en) * 1981-12-22 1985-09-24 Boehringer Mannheim Gmbh Process and reagent for the determination of creatinine
US4790979A (en) * 1986-08-29 1988-12-13 Technimed Corporation Test strip and fixture
US5006474A (en) * 1987-12-16 1991-04-09 Disease Detection International Inc. Bi-directional lateral chromatographic test device
US5055195A (en) * 1983-07-02 1991-10-08 Boehringer Mannheim Gmbh Erythrocyte-retention substrates
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5385847A (en) * 1993-12-02 1995-01-31 Miles Inc. Method for the determination of urinary protein and creatinine
US5464777A (en) * 1994-09-26 1995-11-07 Miles Inc. Dry reagent for creatinine assay
US5610073A (en) * 1995-09-26 1997-03-11 Bayer Corporation Use of CO2 absorbant for stabilization of dried alkaline reagent in creatinine assay
US5662867A (en) * 1991-12-09 1997-09-02 Bayer Corporation System for creatinine determination
US5712170A (en) * 1992-12-29 1998-01-27 Oy Medix Biochemica Ab Test strip, its production and use
US5733787A (en) * 1996-06-17 1998-03-31 Bayer Corporation Method for the detection of creatinine
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US5814522A (en) * 1995-06-24 1998-09-29 Boeringer Mannheim Gmbh Multilayer analytical element for the determination of an analyte in a liquid
US5824554A (en) * 1994-09-09 1998-10-20 Mckay; Florine M. Detection of allergenic substances in food products
US5916815A (en) * 1997-02-14 1999-06-29 National Medical Review Office Inc. Assaying system for illicit substances using intentional false positives to initially preserve anonymity
US5955370A (en) * 1993-11-02 1999-09-21 U.D. Testing, Inc. Urine adulteration test method
US6001656A (en) * 1998-09-28 1999-12-14 Bayer Corporation Method for the detection of creatinine
US6130054A (en) * 1997-12-19 2000-10-10 Unitika Ltd. Test strip for creatine kinase activity measurement
US6136801A (en) * 1998-12-24 2000-10-24 U. D. Testing, Inc. Therapeutic agent with quantitative consumption marker
US6162639A (en) * 1997-12-19 2000-12-19 Amira Medical Embossed test strip system
US6203757B1 (en) * 1998-12-02 2001-03-20 Bionike, Inc. Fluid sample distriution system for test device
US6210971B1 (en) * 1999-01-25 2001-04-03 Bayer Corporation Assay for the detection of creatinine
US6258045B1 (en) * 1998-10-09 2001-07-10 Flexsite Diagnostics, Inc. Collection device for biological samples and methods of use
US6297020B1 (en) * 1999-03-01 2001-10-02 Bayer Corporation Device for carrying out lateral-flow assays involving more than one analyte
US6297060B1 (en) * 1990-03-12 2001-10-02 Biosite Diagnostics, Inc. Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US6312888B1 (en) * 1998-06-10 2001-11-06 Abbott Laboratories Diagnostic assay for a sample of biological fluid
US6376251B1 (en) * 1999-02-03 2002-04-23 Medtox Scientific, Inc. On-site drug testing method
US20020132267A1 (en) * 2000-07-21 2002-09-19 Wong Raphael C. Combination drug test and adulterant test device
US20020155028A1 (en) * 2001-04-23 2002-10-24 Wong Raphael C. Lateral flow contact test apparatus
US6514769B2 (en) * 1999-07-29 2003-02-04 Jin Po Lee Multiple analyte assay device with sample integrity monitoring system
US20030027350A1 (en) * 2001-07-20 2003-02-06 Smith Jack V. Method for detection of bromine in urine using liquid chemistry, dry chemistry test pads, and lateral flow
US6566051B1 (en) * 1999-01-15 2003-05-20 Medtox Scientific, Inc. Lateral flow test strip

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832134A (en) * 1971-10-04 1974-08-27 D Sohn Tlc method and device for detecting the presence of target substances in unknown solutions
US4094647A (en) * 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4844866A (en) * 1984-11-13 1989-07-04 Matrix Technologies, Inc. Carrier for detecting drug abuse compounds
US4803170A (en) * 1985-05-09 1989-02-07 Ultra Diagnostics Corporation Competitive immunoassay method, device and test kit
US4769215A (en) * 1987-03-24 1988-09-06 Franklin Diagnostics, Inc. Integrity preserving and determining urine sample collection apparatus
US5334513A (en) * 1988-05-17 1994-08-02 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
US5465713A (en) * 1988-09-08 1995-11-14 Sudor Partners Energy-assisted transdermal collection patch for accelerated analyte collection and method of use
US5203327A (en) * 1988-09-08 1993-04-20 Sudor Partners Method and apparatus for determination of chemical species in body fluid
ES2081924T3 (en) 1990-02-22 1996-03-16 Editek Inc MULTIPLE LAYER DIAGNOSTIC TEST DEVICE TO DETERMINE THE PRESENCE OF SUBSTANCES IN LIQUID MEDIA.
AU646242B2 (en) * 1990-05-29 1994-02-17 Becton Dickinson & Company Capillary inoculator and assembly for inoculating multiple test sites and method of inoculating test sites therewith
US5200321A (en) * 1990-09-07 1993-04-06 The United States Of America As Represented By The Secretary Of The Navy Microassay on a card
US5356782A (en) * 1992-09-03 1994-10-18 Boehringer Mannheim Corporation Analytical test apparatus with on board negative and positive control
DE4323672A1 (en) * 1993-07-15 1995-01-19 Boehringer Mannheim Gmbh Device for the simultaneous determination of analytes
WO1995017965A1 (en) * 1993-12-28 1995-07-06 Abbott Laboratories Devices having subsurface flow and their use in diagnostic assays
US5710005A (en) * 1996-10-29 1998-01-20 Biocode, Inc. Analyte detection with a gradient lateral flow device
DE19753849A1 (en) * 1997-12-04 1999-06-10 Roche Diagnostics Gmbh Analytical test element with a tapered capillary channel

Patent Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256693A (en) * 1978-06-06 1981-03-17 Fuji Photo Film Co., Ltd. Multilayered integral chemical analysis element for the blood
US4215197A (en) * 1978-08-04 1980-07-29 Miles Laboratories, Inc. Test means and method for creatinine determination
US4543325A (en) * 1981-12-22 1985-09-24 Boehringer Mannheim Gmbh Process and reagent for the determination of creatinine
US4529708A (en) * 1983-04-07 1985-07-16 American Monitor Corporation Assay for the determination of creatinine
US5055195A (en) * 1983-07-02 1991-10-08 Boehringer Mannheim Gmbh Erythrocyte-retention substrates
US4790979A (en) * 1986-08-29 1988-12-13 Technimed Corporation Test strip and fixture
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US5006474A (en) * 1987-12-16 1991-04-09 Disease Detection International Inc. Bi-directional lateral chromatographic test device
US6297060B1 (en) * 1990-03-12 2001-10-02 Biosite Diagnostics, Inc. Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5662867A (en) * 1991-12-09 1997-09-02 Bayer Corporation System for creatinine determination
US5712170A (en) * 1992-12-29 1998-01-27 Oy Medix Biochemica Ab Test strip, its production and use
US5955370A (en) * 1993-11-02 1999-09-21 U.D. Testing, Inc. Urine adulteration test method
US5385847A (en) * 1993-12-02 1995-01-31 Miles Inc. Method for the determination of urinary protein and creatinine
US5824554A (en) * 1994-09-09 1998-10-20 Mckay; Florine M. Detection of allergenic substances in food products
US5464777A (en) * 1994-09-26 1995-11-07 Miles Inc. Dry reagent for creatinine assay
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US5814522A (en) * 1995-06-24 1998-09-29 Boeringer Mannheim Gmbh Multilayer analytical element for the determination of an analyte in a liquid
US5610073A (en) * 1995-09-26 1997-03-11 Bayer Corporation Use of CO2 absorbant for stabilization of dried alkaline reagent in creatinine assay
US5733787A (en) * 1996-06-17 1998-03-31 Bayer Corporation Method for the detection of creatinine
US5916815A (en) * 1997-02-14 1999-06-29 National Medical Review Office Inc. Assaying system for illicit substances using intentional false positives to initially preserve anonymity
US6130054A (en) * 1997-12-19 2000-10-10 Unitika Ltd. Test strip for creatine kinase activity measurement
US6162639A (en) * 1997-12-19 2000-12-19 Amira Medical Embossed test strip system
US6312888B1 (en) * 1998-06-10 2001-11-06 Abbott Laboratories Diagnostic assay for a sample of biological fluid
US6001656A (en) * 1998-09-28 1999-12-14 Bayer Corporation Method for the detection of creatinine
US6258045B1 (en) * 1998-10-09 2001-07-10 Flexsite Diagnostics, Inc. Collection device for biological samples and methods of use
US6203757B1 (en) * 1998-12-02 2001-03-20 Bionike, Inc. Fluid sample distriution system for test device
US6136801A (en) * 1998-12-24 2000-10-24 U. D. Testing, Inc. Therapeutic agent with quantitative consumption marker
US6566051B1 (en) * 1999-01-15 2003-05-20 Medtox Scientific, Inc. Lateral flow test strip
US6210971B1 (en) * 1999-01-25 2001-04-03 Bayer Corporation Assay for the detection of creatinine
US6376251B1 (en) * 1999-02-03 2002-04-23 Medtox Scientific, Inc. On-site drug testing method
US6297020B1 (en) * 1999-03-01 2001-10-02 Bayer Corporation Device for carrying out lateral-flow assays involving more than one analyte
US6514769B2 (en) * 1999-07-29 2003-02-04 Jin Po Lee Multiple analyte assay device with sample integrity monitoring system
US20020132267A1 (en) * 2000-07-21 2002-09-19 Wong Raphael C. Combination drug test and adulterant test device
US20020155028A1 (en) * 2001-04-23 2002-10-24 Wong Raphael C. Lateral flow contact test apparatus
US20030027350A1 (en) * 2001-07-20 2003-02-06 Smith Jack V. Method for detection of bromine in urine using liquid chemistry, dry chemistry test pads, and lateral flow

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9127057B2 (en) 2010-07-20 2015-09-08 Teva Pharmaceuticals Ausralia Pty Ltd Anti-IL-23 heterodimer specific antibodies
WO2012009760A1 (en) 2010-07-20 2012-01-26 Cephalon Australia Pty Ltd Anti-il-23 heterodimer specific antibodies
WO2012142656A1 (en) 2011-04-18 2012-10-26 Garvan Institute Of Medical Research Method of diagnosing cancer
EP3495389A1 (en) 2011-09-30 2019-06-12 Teva Pharmaceuticals Australia Pty Ltd Antibodies against tl1a and uses thereof
CN103808714A (en) * 2012-11-05 2014-05-21 郑兆珉 Biomedical detection device
US10781255B2 (en) 2013-02-01 2020-09-22 Dendrocyte Biotech Pty Ltd Anti-CD83 antibodies and use thereof
US11725054B2 (en) 2013-02-01 2023-08-15 Kira Biotech Pty Limited Anti-CD83 antibodies and use thereof
US9840559B2 (en) 2013-02-01 2017-12-12 The Regents Of The University Of California Anti-CD83 antibodies and use thereof
EP3626743A1 (en) 2013-02-01 2020-03-25 Kira Biotech Pty Limited Anti-cd83 antibodies and use thereof
EP4219552A2 (en) 2013-02-07 2023-08-02 CSL Ltd. Il-11r binding proteins and uses thereof
WO2016041010A1 (en) 2014-09-15 2016-03-24 Garvan Institute Of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
US10870704B2 (en) 2014-10-23 2020-12-22 Kira Biotech Pty Limited CD83 binding proteins and uses thereof
EP4015624A1 (en) 2015-05-05 2022-06-22 Mesoblast International Sàrl Potency assay
WO2016177805A1 (en) 2015-05-05 2016-11-10 Mesoblast International Sàrl Potency assay
EP4137562A1 (en) 2017-05-04 2023-02-22 Mesoblast International Sàrl Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
WO2018202853A1 (en) 2017-05-04 2018-11-08 Mesoblast International Sàrl Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
WO2020141473A1 (en) 2019-01-02 2020-07-09 Mesoblast International Sárl Method for treating lower back pain
WO2022034467A1 (en) 2020-08-10 2022-02-17 Mesoblast International Sarl A composition comprising mesenchymal precursor or stem cells and their use
WO2024009226A1 (en) 2022-07-05 2024-01-11 Mesoblast International Sarl Cryopreserved intermediate and potency assay for same

Also Published As

Publication number Publication date
WO2000042430A1 (en) 2000-07-20
WO2000042430A9 (en) 2002-03-14
US20040023364A1 (en) 2004-02-05
CA2360044A1 (en) 2000-07-20
EP1159611A1 (en) 2001-12-05
WO2000042430A8 (en) 2000-10-26
US6566051B1 (en) 2003-05-20
US20050208677A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
US20040228761A1 (en) Lateral flow test strip
US6592815B1 (en) Analytical test element with a narrowed capillary channel
US5916521A (en) Lateral flow filter devices for separation of body fluids from particulate materials
JP2937568B2 (en) Self-measuring fluid analyzer
US5399486A (en) Disposable unit in diagnostic assays
EP3385713B1 (en) Lateral flow assay device
JP4322506B2 (en) Analytical test equipment
US4308028A (en) Device and method for the chemical testing and microscopic examination of liquid specimens
US4948564A (en) Multi-well filter strip and composite assemblies
US5409664A (en) Laminated assay device
EP1390748B1 (en) Lateral flow contact test apparatus
EP0339769A1 (en) Multi-well filter strip and composite assemblies
JP2002510392A (en) Analyte measuring device in body fluid
US7820451B2 (en) Analytical test element
JP6199527B1 (en) Lateral flow assay device with filtered flow control
WO2010079479A2 (en) A multiple testing apparatus and method
US5783401A (en) Immunoenzymatic detection device
RU2281165C2 (en) Device for drawing liquid samples
EP3378559B1 (en) Detection apparatus for detecting analyte in a liquid sample
CA2389741C (en) Assay device and use thereof
CN210123442U (en) Device for detecting misfolded proteins
WO1992015863A1 (en) Improved test strip
US20060205086A1 (en) Diagnostic device
CN110249221B (en) Vertical flow test device for detecting glucose concentration in a fluid sample
CN113347926A (en) Simultaneous in-situ testing and storage of blood samples

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION